Alnylam Pharmaceuticals
ALNY
#659
Rank
โ‚ฌ28.99 B
Marketcap
224,81ย โ‚ฌ
Share price
-8.02%
Change (1 day)
43.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company